Towards the Burden of Human Leptospirosis: Duration of Acute Illness and Occurrence of Post-Leptospirosis Symptoms of Patients in The Netherlands
Adult
Male
0301 basic medicine
Science
EMC MM-04-27-01
03 medical and health sciences
SDG 3 - Good Health and Well-being
Surveys and Questionnaires
Humans
Leptospirosis
Netherlands
Retrospective Studies
Leptospira
Q
R
Middle Aged
Bacterial Typing Techniques
3. Good health
Hospitalization
Intensive Care Units
Acute Disease
Medicine
Female
Research Article
DOI:
10.1371/journal.pone.0076549
Publication Date:
2013-10-03T20:56:52Z
AUTHORS (9)
ABSTRACT
BackgroundLeptospirosis is a global zoonotic disease. Although important for the assessment of burden leptospirosis, data on duration illness and occurrence post-leptospirosis complaints are not well documented. Hence main objective this study was to estimate persistent hospital stay in laboratory confirmed leptospirosis patients Netherlands during 1985 2010. Additionally, several risk factors potentially impacting were investigated. Methods/Principal FindingsThe acute phase 16 days (IQR 12–23); 10 7–16) spent hospitalized. Eighteen fatal cases excluded from analysis. Complaints by passive case investigations (CPC) derived files ambulant consultations occurring one month after discharge, revealed 108 236 (45.8%) cases. Data (PCAC), assessed 225 collected through questionnaires 1985-1993, indicated 68 (30.2%) PCAC Frequently reported included (extreme) fatigue, myalgia, malaise, headache, weak physical condition. These prolonged 21.1% beyond 24 months onset There no association between hospitalization. However, individuals admitted at intensive care unit (ICU) twice as likely have continuing discharge adjusting age dialysis (OR 2.0 95% CI 0.8-4.8). No significant could be found prolongation infecting serogroup, although subgroup analysis suggest that infection with serogroups Sejroe 4.8, 95%CI 0.9-27.0) icterohaemorrhagiae 2.0, 0.9-4.3 CI) more result CPC than infections serogroup Grippotyphosa. Conclusion/SignificanceIn addition disease, an impact leptospirosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (54)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....